Health
Discovery of Immune Protein IL-18 Offers Hope for Pancreatic Cancer Treatment Combinations
Researchers at MD Anderson have identified Interleukin-18 as a key factor in pancreatic cancer’s immune evasion, opening paths for new combination therapies.